Sunshine Biopharma (SBFM) Short Interest Ratio & Short Volume → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free SBFM Stock Alerts $0.99 -0.03 (-2.94%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Sunshine Biopharma Short Interest DataCurrent Short Volume69,800 sharesPrevious Short Volume706,700 sharesChange Vs. Previous Month-90.12%Dollar Volume Sold Short$426,478.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares995,000 sharesFloat Size953,400 sharesShort Percent of Float7.32%Today's Trading Volume3,217,768 sharesAverage Trading Volume1,713,444 sharesToday's Volume Vs. Average188% Short Selling Sunshine Biopharma ? Sign up to receive the latest short interest report for Sunshine Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSBFM Short Interest Over TimeSBFM Days to Cover Over TimeSBFM Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Sunshine Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202469,800 shares $426,478.00 -90.1%7.3%0.1 $6.11 3/31/2024706,700 shares $42,755.35 -27.2%0.8%0 $0.06 3/15/2024971,000 shares $58,260.00 +118.1%1.1%0.1 $0.06 2/29/2024445,300 shares $24,669.62 -26.1%1.0%0 $0.06 2/15/2024602,600 shares $38,265.10 +487.3%1.3%0.3 $0.06 1/31/2024102,600 shares $26,265.60 -9.1%0.4%0.5 $0.26 Get the Latest News and Ratings for SBFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024112,900 shares $28,642.73 -1.6%0.5%0.7 $0.25 12/31/2023114,700 shares $31,141.05 +90.5%0.5%0.7 $0.27 12/15/202360,200 shares $14,327.60 -18.9%0.3%0.4 $0.24 11/30/202374,200 shares $21,443.80 -22.4%0.3%0.5 $0.29 11/15/202395,600 shares $26,194.40 -29.2%0.4%0.7 $0.27 10/31/2023135,100 shares $40,421.92 -35.0%0.6%0.9 $0.30 10/15/2023207,700 shares $66,443.23 +8.6%1.0%1.3 $0.32 9/30/2023191,200 shares $61,184.00 +3.4%0.9%1.1 $0.32 9/15/2023184,900 shares $73,368.32 -34.3%0.9%1.1 $0.40 8/31/2023281,200 shares $120,606.68 -52.5%1.3%1.5 $0.43 8/15/2023591,900 shares $307,788.00 +701.0%2.8%2.7 $0.52 7/31/202373,900 shares $37,689.00 -52.7%0.4%0.1 $0.51 7/15/2023156,300 shares $75,070.89 -32.2%0.9%0.1 $0.48 6/30/2023230,500 shares $113,982.25 -28.9%1.3%0.2 $0.49 6/15/2023324,000 shares $179,755.20 -39.9%1.8%0.2 $0.55 5/31/2023538,800 shares $328,668.00 -67.5%3.0%0.4 $0.61 5/15/20231,660,000 shares $1.05 million +525.9%9.2%1.3 $0.63 4/30/2023265,200 shares $165,935.64 -6.1%1.5%2.1 $0.63 4/15/2023282,500 shares $192,100.00 +28.1%1.5%1.9 $0.68 3/31/2023220,600 shares $161,214.48 -27.7%1.2%1.1 $0.73 3/15/2023305,300 shares $242,835.62 -13.8%1.7%1.4 $0.80 2/28/2023354,100 shares $319,079.51 -16.9%1.9%1.6 $0.90 2/15/2023426,000 shares $415,137.00 +7.6%2.3%1.9 $0.97 1/31/2023395,800 shares $486,834.00 +28.6%2.1%1.1 $1.23 1/15/2023307,900 shares $253,309.33 -19.4%1.7%0.8 $0.82 12/30/2022381,900 shares $244,416.00 -15.2%2.1%0.7 $0.64 12/15/2022450,400 shares $307,262.88 -5.8%2.5%0.9 $0.68 11/30/2022478,300 shares $378,383.13 +14.0%2.9%0.8 $0.79 11/15/2022419,600 shares $351,163.24 -21.9%2.5%0.7 $0.84 10/31/2022537,200 shares $459,467.16 +1,239.7%3.2%1.1 $0.86 10/15/202240,100 shares $32,280.50 -46.5%0.3%0 $0.81 9/30/202275,000 shares $57,937.50 -30.7%0.5%0.1 $0.77 9/15/2022108,200 shares $105,094.66 -72.7%0.7%0.1 $0.97 8/31/2022396,100 shares $435,710.00 -32.9%2.5%0.4 $1.10The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. SBFM Short Interest - Frequently Asked Questions What is Sunshine Biopharma's current short interest? Short interest is the volume of Sunshine Biopharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 69,800 shares of SBFM short. 7.32% of Sunshine Biopharma's shares are currently sold short. Learn More on Sunshine Biopharma's current short interest. What is a good short interest percentage for Sunshine Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.32% of Sunshine Biopharma's floating shares are currently sold short. Is Sunshine Biopharma's short interest increasing or decreasing? Sunshine Biopharma saw a decline in short interest in April. As of April 15th, there was short interest totaling 69,800 shares, a decline of 90.1% from the previous total of 706,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sunshine Biopharma's float size? Sunshine Biopharma currently has issued a total of 995,000 shares. Some of Sunshine Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sunshine Biopharma currently has a public float of 953,400 shares. How does Sunshine Biopharma's short interest compare to its competitors? 7.32% of Sunshine Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Sunshine Biopharma: Evelo Biosciences, Inc. (2.11%), SciSparc Ltd. (21.38%), GRI Bio, Inc. (0.61%), Biodexa Pharmaceuticals Plc (14.70%), Panbela Therapeutics, Inc. (2.36%), Lucy Scientific Discovery Inc. (1.69%), Comera Life Sciences Holdings, Inc. (2.38%), China SXT Pharmaceuticals, Inc. (11.61%), NeuBase Therapeutics, Inc. (0.81%), Aptevo Therapeutics Inc. (9.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Sunshine Biopharma stock? Short selling SBFM is an investing strategy that aims to generate trading profit from Sunshine Biopharma as its price is falling. SBFM shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sunshine Biopharma? A short squeeze for Sunshine Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SBFM, which in turn drives the price of the stock up even further. How often is Sunshine Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SBFM, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Evelo Biosciences Short Interest Data SciSparc Short Interest Data GRI Bio Short Interest Data Biodexa Pharmaceuticals Short Interest Data Panbela Therapeutics Short Interest Data Lucy Scientific Discovery Short Interest Data Comera Life Sciences Short Interest Data China SXT Pharmaceuticals Short Interest Data NeuBase Therapeutics Short Interest Data Aptevo Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SBFM) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society